Imugene (IMU) News Today → Henry Kissinger’s chilling AI warning (From Chaikin Analytics) (Ad) Free IMU Stock Alerts Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineCell therapy firm acquires RTP manufacturing facilitybizjournals.com - April 17 at 10:23 AMImugene partners with Kincell Bio; selling cell therapy manufacturing facility for $6 millionfinance.yahoo.com - April 16 at 1:54 PMBile Tract Cancer expansion study opens following clearance of Imugene’s MAST trial high dose cohortmarkets.businessinsider.com - April 15 at 8:13 PMBile Tract Cancer expansion study opens following clearance of Imugene’s MAST trial high dose cohortfinance.yahoo.com - April 15 at 8:13 PMImugene opens enrolment for Bile Tract Cancer expansion studyfinance.yahoo.com - April 15 at 3:12 PMASX Health Stocks: Atomo sells more HIV Self-Tests; Actinogen begins Phase 2b trial on Alzheimer’smsn.com - April 15 at 12:02 AMCity of Hope Scientists Present Leading-Edge Research at American Association for Cancer Research (AACR) Annual Meetingfinance.yahoo.com - April 10 at 8:25 PMImugene Limited: Imugene's oncolytic virotherapy VAXINIA and B cell immunotherapy HER-Vaxx featured at the AACR Annual Meeting 2024finanznachrichten.de - April 9 at 6:38 PMImugene's oncolytic virotherapy VAXINIA and B cell immunotherapy HER-Vaxx featured at the AACR Annual Meeting 2024finance.yahoo.com - April 9 at 1:37 PMGuess which ASX 300 healthcare stock is storming higher on Chinese patent newsmsn.com - April 3 at 9:41 PMPrecision BioSciences Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Provides Business Updatefinance.yahoo.com - March 27 at 6:55 AMU.S. Food and Drug Administration (FDA) Has Accepted the New Drug Application (NDA) for Ensartinibfinance.yahoo.com - March 15 at 4:04 PMPendulum Therapeutics Introduces GLP-1 Probioticfinance.yahoo.com - March 14 at 7:22 AMUnityPoint in Des Moines releases renderings for mental health expansionfinance.yahoo.com - March 13 at 12:47 PMNovartis Acquires IFM Due to Develop First-In-Class STING Antagonist Program Targeting Innate Immune Systemfinance.yahoo.com - March 13 at 7:47 AMapoQlar enters into Collaboration with Mayo Clinic to Advance Patient Care with Extended Reality Technologyfinance.yahoo.com - March 12 at 10:29 AMImugene Limited: Phase 1 onCARlytics solid tumour trial advances to combination arm treatmentfinanznachrichten.de - March 11 at 10:49 PMFIVE at FIVE AU: Biggest fall on ASX in eight monthsau.investing.com - March 11 at 7:48 AMImugene advances to combination dosing with Phase 1 onCARlytics solid tumour trialau.investing.com - March 11 at 1:32 AMBarrenjoey, Canaccord raising for Lake Resources; 39.1pc discountafr.com - March 10 at 8:31 PMImugene Highlights Recent Achievements and Looks Ahead to Key Upcoming Immuno-oncology Catalystsfinance.yahoo.com - February 22 at 12:13 PM4 things a doctor who's written best-selling books about aging does daily in the hope of living longermsn.com - February 20 at 6:14 PMImugene doses first patient in intravenous monotherapy arm of Phase 1 clinical trialproactiveinvestors.com - February 15 at 2:58 AMBritish Punjabi doctor leads ground-breaking international trial of bowel cancer vaccinemsn.com - February 3 at 3:28 PMMaxCyte Signs Strategic Platform License with Imugene to Advance their Cancer Immunotherapy Programsfinance.yahoo.com - January 23 at 8:43 AMImugene's CF33-hNIS (VAXINIA) & MAST Study Featured at ASCO GI Cancers Symposiumfinance.yahoo.com - January 19 at 12:18 AMImugene achieves ‘complete response’ with mid dose cancer trialproactiveinvestors.com - January 18 at 7:17 PMWhy is ASX 300 healthcare stock Imugene jumping 14% today?fool.com.au - January 16 at 8:40 PMASX Health Stocks: Imugene gains on positive early signs from Phase 1 trialmsn.com - January 16 at 8:40 PMImugene well positioned to deliver 2024 milestonesau.investing.com - December 28 at 11:47 PMImugene Ltd IUGNFmorningstar.com - December 20 at 6:18 PMImugene and NeoImmuneTech in alliance to advance cancer treatmentau.investing.com - December 11 at 11:45 PMNeoImmuneTech and Imugene enter into strategic research collaboration to improve cancer treatmentsfinance.yahoo.com - December 11 at 6:45 PMImugene to open new PD1-Vaxx Phase 2 bowel cancer clinical trial in UK and Australiaproactiveinvestors.com.au - December 7 at 3:43 AMImugene to commence new phase 2 PD1-Vaxx bowel cancer trialfinance.yahoo.com - December 6 at 3:48 PMImugene to be granted European patent for cancer vaccineproactiveinvestors.com - December 5 at 10:49 PMWhy Collins Foods, Healius, Imugene, and Link shares are climbing todayfool.com.au - November 29 at 12:40 AMImugene thrilled as VAXINIA granted FDA Fast Track designationproactiveinvestors.com - November 27 at 11:58 PMImugene share price jumps 32% on FDA newsfool.com.au - November 27 at 6:58 PMImugene opens higher as novel cancer-killing virus VAXINIA is granted FDA Fast Track designationproactiveinvestors.com.au - November 27 at 6:58 PMImugene Ltd IMUmorningstar.com - November 16 at 7:22 PMWhile Imugene (ASX:IMU) shareholders have made 304% in 5 years, increasing losses might now be front of mind as stock sheds 12% this weekfinance.yahoo.com - November 16 at 7:22 PMImugene says Azer-cel could be best-in-class Allogeneic CAR Tproactiveinvestors.com - November 13 at 12:27 AMWhy Avita Medical, Imugene, Pantoro, and Tietto shares are pushing higherfool.com.au - November 10 at 12:52 AMImugene share price jumps 34% on 'major milestone': What is it?fool.com.au - November 10 at 12:52 AMImugene doses first patient in Phase 1b Allogeneic CAR T Clinical Trialau.investing.com - November 9 at 7:51 PMWhy Imugene, Lottery Corp, Orica, and Sayona Mining shares are storming higherfool.com.au - November 9 at 12:12 AMGuess which ASX All Ords stock is up 60% in just two daysfool.com.au - November 8 at 9:11 AMImugene’s positive initial VAXINIA MAST trial data prompts analyst optimism; 46 cents targetproactiveinvestors.com.au - November 8 at 12:54 AMPrecision BioSciences Inc (DTIL) Reports Q3 2023 Financial Resultsfinance.yahoo.com - November 7 at 9:52 AM Get Imugene News Delivered to You Automatically Sign up to receive the latest news and ratings for IMU and its competitors with MarketBeat's FREE daily newsletter. Email Address Henry Kissinger’s chilling AI warning (Ad)Not long before his death in 2023, Henry Kissinger wrote about a "world of potentially total destructiveness and substantial uncertainty." He was talking about the advent of generative artificial intelligence (AI)... And how we are woefully unprepared for the consequences this technology could bring. Just click right here to access this new research 100% free while it’s still available. IMU Media Mentions By Week IMU Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IMU News Sentiment▼-0.360.49▲Average Medical News Sentiment IMU News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IMU Articles This Week▼62▲IMU Articles Average Week Get Imugene News Delivered to You Automatically Sign up to receive the latest news and ratings for IMU and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Algernon Pharmaceuticals News ALK-Abelló A/S News Alpha Tau Medical News Arno Therapeutics News Artelo Biosciences News Ascletis Pharma News Awakn Life Sciences News AXIM Biotechnologies News BerGenBio ASA News BriaCell Therapeutics News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (ASX:IMU) was last updated on 4/18/2024 by MarketBeat.com Staff From Our Partners[Urgent!] Generational Wealth GameplanCrypto 101 MediaThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingBiden’s $374B Giveaway Into This SectorDTIForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressHe Is Giving Away BitcoinCrypto Swap ProfitsThe Next Nvidia?InvestorPlaceHow Biden has already won 2024Porter & CompanyOptions trading has suddenly become more reliable.Eagle Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Imugene Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.